AH
TNGX icon

Aviva Holdings’s Tango Therapeutics TNGX Stock Holding History

Aviva Holdings’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-26,961
Closed -$304K – 3
2023
Q3 		$304K Hold
26,961
– – 0.2% 4
2023
Q2 		$90K Hold
26,961
– – 0.07% 4
2023
Q1 		$106K Hold
26,961
– – 0.07% 4
2022
Q4 		$195K Hold
26,961
– – 0.11% 4
2022
Q3 		$98K Hold
26,961
– – 0.04% 5
2022
Q2 		$122K Hold
26,961
– – 0.04% 5
2022
Q1 		$204K Hold
26,961
– – 0.05% 5
2021
Q4 		$295K Hold
26,961
– – 0.05% 5
2021
Q3 		$349K Buy
+26,961
New +$323K 0.05% 5

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return